In Ewing's sarcoma family tumors (ESFTs), the proto-oncogene EWS that encodes an RNA-binding protein is fused by chromosomal translocation to the gene encoding one of the E-twenty six (ETS) family of transcription factors, most commonly friend leukemia virus integration 1 (FLI-1). Although EWS/FLI-1 chimeric proteins are necessary for carcinogenesis, additional events seem to be required for transformation to occur. We have previously reported that a protein product of an EWS mRNA target, whose expression is negatively regulated by EWS but not by EWS/FLI-1, contributes to ESFT development. However, the mechanism by which EWS represses protein expression remains to be elucidated. Here, we report that overexpression of full-length EWS repressed protein expression and induced nuclear retention of reporter mRNAs in a tethering assay. In contrast, when a mutant lacking the EWS C-terminal nuclear localization signal (classified as a PY-NLS) was expressed, reporter protein expression was upregulated, and the number of cells exporting reporter mRNA to the cytoplasm increased. EWS binds to the 3 0 -untranslated region in another mRNA target, cofilin 1 (CFL1), and negatively regulates the expression of CFL1. Overexpression of EWS induced nuclear retention of CFL1 mRNA. Furthermore, ESFT cell proliferation and metastatic potential were suppressed by small interfering RNA-mediated CFL1 knockdown. Together, our findings suggest that EWS induces nuclear retention of CFL1 mRNA, thereby suppressing expression of CFL1, and that CFL1 promotes development of ESFT. Targeting CFL1 might therefore provide another novel approach for treatment of this aggressive disease.
INTRODUCTION
Ewing's sarcoma, an aggressive tumor, is the second most common malignancy of bone and soft tissue afflicting young patients. EWS (also known as EWSR1, Ewing sarcoma break point region 1) encodes an RNA-binding protein that belongs to the FET family (previously, TET family) of proteins, along with FUS (also known as TLS) and TAF15 (also known as TAFII68). Although the function of FET proteins has not been fully elucidated, they are known to play roles in diverse biological processes, which include transcription, splicing, microRNA processing, RNA transport, signaling and maintenance of genomic integrity. 1 FET proteins are involved in chromosomal translocations, resulting in fusions with a variety of transcription factors, in several human tumors.
In 85% of Ewing's sarcoma family tumors (ESFTs), the EWS/FLI-1 fusion protein resulting from the (11;22)(q24;q12) chromosomal translocation is observed. However, EWS/FLI-1 alone is not sufficient to confer sarcomatous change. Other events, including deregulation of the p53 pathway 2 and loss of the p16 pathway, 3 are also responsible for the progression of this tumor. Loss of function of EWS protein due to haploinsufficiency caused by the chromosomal translocation, which disrupts at least one allele of the EWS gene, might also contribute to tumorigenesis. In support of this idea, the expression levels of EWS protein are decreased in several ESFT cell lines. 4, 5 During a study aimed at elucidating the roles of native EWS protein, we found that EWS repressed protein expression from mRNAs with which it associates in cells. 5 Although the detailed mechanism underlying this negative regulation remains to be determined, our results suggest that EWS represses nuclear export or translation, or both, of its mRNA targets. In cultured cells, EWS mostly localizes to the nucleus, where it has been implicated in transcription and pre-mRNA splicing. [6] [7] [8] In addition, EWS is capable of nuclear-cytoplasmic shuttling, raising the possibility that it is involved in nuclear export of mRNA. 9 Accordingly, we hypothesized that EWS plays a role in the regulation of nuclear export of mRNA. In a tethering assay, we found that DC-NLS, a mutant that lacks the C-terminal nuclear localization signal (C-NLS) of EWS, led to a significant increase in protein expression from a reporter mRNA, in contrast to the decrease resulting from full-length EWS. By investigating mRNA localization, we found that EWS induced nuclear retention of the reporter mRNA, whereas DC-NLS allowed the mRNA to be exported from the nucleus. We then demonstrated that an mRNA target of EWS, cofilin 1 (CFL1), is also repressed by EWS at the levels of protein expression and mRNA nuclear export via an interaction mediated through its 3 0 -untranslated region (UTR). Knockdown of CFL1 led to inhibition of proliferation, migration and invasion of ESFT cells. CFL1 upregulation might be another significant event, along with chromosomal translocation, in the progression of ESFT. Therefore, CFL1 might represent a novel therapeutic target for treatment of ESFT.
RESULTS
Overexpression of EWS repressed reporter expression and induced nuclear retention of reporter mRNA in a tethering assay EWS generally localizes to the nucleus due to the function of its C-NLS, 9 which is classified as a PY-NLS because it contains a proline-tyrosine pair at its C-terminus. 10 To examine the possibility that the localization of EWS contributes to the mechanism by which it represses protein expression, we constructed an EWS deletion mutant, DC-NLS, in which the C-NLS was deleted (Figure 1a ). EWS and DC-NLS were then forced to bind or tethered to firefly luciferase (FLuc) reporter mRNA. To do this, we utilized a specific interaction of the coat protein from the MS2 phage to a particular stem-loop structured RNA (MS2-binding site): reporter vectors contained an intron in the 5 0 -UTR and 12 and 0 copies of the MS2-binding site in the 3 0 -UTR (FLuc-MS2BS and FLuc, respectively). 5 HeLa S3 cells were transfected with expression vectors for MS2, MS2-EWS or MS2-DC-NLS together with the FLuc-MS2BS or FLuc reporter vectors. Fusion with MS2 protein brings EWS and DC-NLS to the FLuc-MS2BS mRNA in this tethering assay. Expression of MS2-EWS fusion protein in cells decreased firefly luciferase activity of FLuc-MS2BS by B50% compared with expression of MS2 alone, as reported previously, 5 whereas expression of MS2-DC-NLS increased the firefly luciferase activity of FLuc-MS2BS B1.8-fold (Figure 1b) . These results implied that C-NLS is important for suppression of protein expression by EWS.
Next, we wished to determine which post-transcriptional step of gene expression is repressed by EWS. The levels and the sizes of the reporter mRNA were not affected by the expression of MS2-EWS or MS2-DC-NLS, relative to expression of MS2 5 (data not shown), indicating that the repression was not likely due to reduction in transcription, splicing or mRNA stability. Furthermore, overexpressed EWS localized to the nucleus but not in cytoplasmic stress granules, indicating that EWS does not accumulate untranslated mRNAs in stress granules (Figure 1c ). We therefore focused on the possible role of EWS in the nuclear export of the mRNAs with which it associates. To address this issue, we investigated the effects of the C-NLS domain on mRNA nuclear export in the tethering assay by in situ hybridization combined with immunofluorescence analysis. MS2-DC-NLS was distributed in the cytoplasm or as dots in the perinuclear region, whereas MS2-EWS localized to the nucleus (Figure 1c) . The reporter mRNA was diffusely distributed in both the cytoplasm and the nucleus of most MS2-expressing cells, with the cytoplasmic signal being higher in 450% of cells (Figures 1c and d) . In 495% of MS2-EWSexpressing cells, the reporter mRNA predominantly remained in the nucleus. By contrast, the reporter mRNA was exported to the cytoplasm of 480% of MS2-DC-NLS-expressing cells. Taken together, the results in Figure 1 indicate that EWS suppressed the nuclear export of a tethered reporter mRNA, thereby repressing protein expression; this repression may be due to the nuclear localization of EWS itself mediated by the C-NLS domain.
EWS binds to CFL1 mRNA and represses CFL1 protein expression The results described above raise the possibility that EWS suppresses protein production by inducing the nuclear retention of mRNAs with which EWS associates. Previously, we searched for mRNAs that bind EWS protein in cells by RNA immunoprecipitation-Chip analysis. We found 907 mRNAs that bind to EWS, including the mRNA encoding CFL1. 5 The 3 0 -UTR of CFL1 mRNA was also identified as an EWS target in photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation analysis by another group.
11 CFL1 is a key regulator for actin filament turnover. 12 At low concentrations, cofilins nucleate actin polymerization by severing actin filaments to generate free barbed ends and increase the rate of actin depolymerization, thereby maintaining a pool of actin monomers. At high concentrations, cofilins bind actin monomers and stimulate nucleation, leading to actin filament assembly. 13 To determine whether EWS affects CFL1 protein expression, we transfected a FLAG-EWS expression vector into HeLa S3 cells. Upon overexpression of FLAG-EWS, the level of CFL1 protein was reduced significantly (B50%) compared with that of control. In contrast, overexpression of FLAG-EWS/FLI-1 did not change the level of CFL1 protein (Figure 2a ). The level of CFL1 mRNA as determined by real-time PCR, however, did not differ significantly in response to EWS overexpression (Figure 2b ), indicating that EWS attenuated CFL1 protein expression without influencing the amount of CFL1 mRNA.
To further clarify the interaction between EWS protein and CFL1 mRNA, we investigated by ultraviolet (UV)-crosslinking analysis whether purified EWS protein bound CFL1 mRNA directly in vitro (Figures 2c-f ). EWS bound to the 32 P-labeled CFL1 3 0 -UTR RNA probe in a manner dependent on UV irradiation, demonstrating that the EWS protein associates with CFL1 3 0 -UTR directly ( Figure 2c ). In contrast, EWS/FLI-1 did not bind to the probe, probably because EWS/FLI-1 lacks the C-terminal RNA-binding domains of EWS (Figure 2c ). To examine the specificity of RNA-binding activity of EWS, we added either unlabeled FLuc mRNA or FLuc-3UTR mRNA, in which the CFL1 3 0 -UTR was cloned downstream of the FLuc-coding region, into the UV-crosslinking assay mixture ( Figure 2d ). When equimolar amounts of FLuc-3UTR mRNA and CFL1 3 0 -UTR RNA probe were added, the amount of EWS bound to the CFL1 3 0 -UTR probe decreased to approximately 40% compared with the CFL1 3 0 -UTR probe alone; when a threefold excess of the FLuc-3UTR mRNA competitor was added, the amount of EWS bound to the probe decreased by an additional 20%. However, the amount of EWS bound to the probe did not change upon addition of an equimolar amount of FLuc mRNA and only decreased to 66% upon addition of a threefold excess of FLuc mRNA (Figures 2e and f ). These results demonstrate the specificity of the interaction between EWS protein and the CFL1 3 0 -UTR.
Expression of CFL1 is repressed by EWS through binding to the CFL1 3 0 -UTR We next examined whether EWS binding to the CFL1 3 0 -UTR is responsible for the downregulation of CFL1 protein expression. Overexpression of FLAG-EWS suppressed the luciferase activity of the FLuc-3UTR reporter to 73% of control (Po0.05) but did not suppress activity of the FLuc reporter ( Figure 3a ). In contrast, overexpression of FLAG-EWS/FLI-1 did not result in any difference between the luciferase activities of the FLuc-3UTR and FLuc reporters. Further, the amount and size of neither FLuc-3UTR nor FLuc reporter mRNA were affected by overexpression of EWS ( Figure 3b ).
To examine the repression of CFL1 expression by EWS further, we then knocked down the expression of EWS in HeLa S3 cells, using small interfering RNAs (siRNAs). Upon EWS knockdown with two different siRNAs (Si1 and Si2), the levels of endogenous CFL1 (Figure 3c ). The luciferase activity of the FLuc-3UTR reporter was augmented B1.7-fold by knockdown of EWS compared with the activity in the absence of siRNA transfection (Figure 3d) . However, the luciferase activity of the FLuc reporter did not show any change by knockdown of EWS (Figure 3d ). There was no effect on the level of either FLuc-3UTR or FLuc reporter mRNA (Figure 3e ). The results of both the overexpression and knockdown experiments indicate that EWS suppresses the production of CFL1 protein post-transcriptionally mediated by the CFL1 3 0 -UTR.
EWS induces the nuclear retention of CFL1 mRNA in ESFT cells Because EWS induced nuclear retention of the reporter mRNA in the tethering assay, we investigated whether EWS induces nuclear retention of CFL1 mRNA. First, we examined the localization of FLuc and FLuc-3UTR reporter mRNAs upon overexpression of Myc-EWS in HeLa cells (Supplementary Figure S1 ). The nuclear-retained FLuc-3UTR reporter mRNA was significantly increased when Myc-EWS was expressed, whereas the localization of FLuc mRNA was not affected by overexpression of EWS. Next, we tested whether endogenous CFL1 mRNA is affected by EWS in ESFT cells. To this end, we transfected a Myc-EWS expression vector into MHH-ES-1 cells derived from ESFT and examined the localization of the endogenous CFL1 mRNA by in situ hybridization (Figure 4 ). CFL1 mRNA exhibited cytoplasmic localization in virtually all cells transfected with an empty vector, whereas when Myc-EWS was expressed, the proportion of cells with a preponderance of nuclear localization of CFL1 mRNA increased to 435%. However, the localization of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was not affected by overexpression of Myc-EWS.
Our results indicate that EWS induces the nuclear retention of CFL1 mRNA, which is mediated by the CFL1 3 0 -UTR. In an attempt to clarify the mechanism by which EWS induces nuclear retention of mRNA, we examined the effect of EWS on the alternative splicing of CFL1 pre-mRNA. We overexpressed Myc-EWS in HeLa S3 cells, as well as the ESFT cell lines A673 and MHH-ES-1, and performed real-time PCR using two primer sets: one to amplify a region spanning from exon 1 to intron 1 (E1-I1, primers P1 and P2) and the other to amplify a region from exons 2 to 4 (E2-E4, primers P3 and P4) (Supplementary Figure S2) . Both primer sets amplified DNA fragments of the expected sizes when a genomic DNA fragment containing the CFL1 gene was used as a template. However, primers P1 and P2 amplified no band from cDNA from cells transfected with either the Myc-EWS expression vector or an empty vector. When primers P3 and P4 were used with cDNA from all cells, only the spliced form without introns was detected (Supplementary Figure S2) . These results suggest that overexpression of EWS did not affect CFL1 splicing and, therefore, that EWS-induced nuclear retention of mRNA is mediated by another mechanism.
CFL1 knockdown suppresses the proliferation and metastatic potential of ESFT cells Increased levels of CFL1 expression have been detected by proteomic and cDNA microarray approaches in clinical tumor samples of oral squamous cell carcinoma, 14 renal cell carcinoma, 15 ovarian cancer 16 and non-small cell lung cancer. 17 In light of these observations, we examined the CFL1 protein levels in ESFT cell lines. Human umbilical vein endothelial cells were used as a Expression of CFL1 is regulated by EWS L Huang et al control because there is a high degree of similarity in gene expression between ESFT cells and human umbilical vein endothelial cells. 18 In all five ESFT cell lines, the CFL1 protein level was significantly higher than that in human umbilical vein endothelial cells (Supplementary Figure S3) .
Ewing's sarcoma is highly metastatic, and approximately 25% of patients exhibit metastatic disease at diagnosis. 19 CFL1 is believed to promote metastasis by regulating turnover of actin filaments in breast cancer, 20 colorectal cancer, 21,22 glioblastoma 23 and prostate cancer. 24 To determine whether CFL1 contributes to the high metastatic potential of ESFT, we conducted cell migration and cell invasion assays in ESFT cells ( Figure 5 ). Upon transfection with a pool of four CFL1 siRNAs (CFL1), the proportion of migrating and invading A673 cells significantly decreased by B50% and B40%, respectively, compared with that of untransfected cells (Figures 5a  and b , also see Figure 6a ), whereas those transfected with control siRNA (Cont) did not exhibit any significant change. Similar results were obtained in MHH-ES-1 cells using two individual CFL1 siRNAs (B40-75% of control in migration and B45-55% of control in invasion) (Figures 5c and d , also see Figures 6d and f) .
We next examined whether CFL1 affected the proliferation of ESFT cells. A673 cells transfected with CFL1 pool siRNAs exhibited a significant decrease in CFL1 protein level and exhibited a remarkable decline of B65% in anchorage-dependent cell proliferation compared with untransfected cells, whereas cells transfected with control siRNAs did not show any significant change (Figures 6a and b) . Anchorage-independent cell proliferation was as low as o20% of the no-siRNA control, whereas proliferation of control siRNA-transfected cells was B70% of the untransfected control level (Figure 6c) . We also performed the same assay in MHH-ES-1 cells (Figures 6d-h ) and SK-N-MC cells (data not shown). For these experiments, we used both CFL1 pool siRNAs and individual siRNAs separated from the pool. MHH-ES-1 cells transfected with CFL1 siRNAs exhibited a remarkable decline in anchorage-dependent and anchorage-independent cell proliferation to B60% and 3-15% of no-siRNA control, respectively, whereas cells transfected with control siRNAs did not show any substantial change. Taken together, the data show that knockdown of CFL1 repressed the proliferation and metastatic potential of ESFT cells.
DISCUSSION
Ewing's sarcoma is characterized as a highly malignant and metastatic tumor with a very low survival rate. 25 Several current treatments, which target the EWS/FLI-1 fusion protein or its downstream factors using chemical compounds or siRNAs, do not result in the favorable outcomes that might be predicted. 26 Recurrent hemizygous deletions are found in multiple tumors, and it has recently been proposed that the cumulative result of haploinsufficiency of several affected genes is sufficient to promote tumorigenesis. 27 Chromosomal translocation of single alleles might create a similar situation, resulting in haploinsufficiency of genes at the chromosomal break point. In most cases of Ewing's sarcoma, chromosomal translocation brings about the formation of oncogenic fusion protein EWS/FLI-1 at the expense of one allele of EWS. Therefore, to find a novel approach to understanding and targeting Ewing's sarcoma, it will be important to elucidate the functional roles of not only EWS/FLI-1 fusion protein but also native EWS. 
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Previously, we found that EWS represses protein expression post-transcriptionally. Using an RNA immunoprecipitation-Chip assay, we identified 907 mRNAs that bind to EWS in cells. 5 mRNA targets of FET proteins have also recently been identified by other groups using RNA immunoprecipitation-Chip or photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation assays. 11, 28 Comparison of the EWS mRNA targets identified by our RNA immunoprecipitation-Chip experiment with those identified by photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation analysis revealed an overlap of 376 out of 907 mRNAs (41%), including CFL1 mRNA. 5, 11 Gene ontology analysis has revealed that the biological processes enriched in mRNA targets of both EWS and FUS include spliceosome assembly and DNA repair. 5, 28 Protein expression of one of the EWS mRNA targets that we identified, PRAS40, is repressed by EWS; importantly, PRAS40 knockdown represses the proliferation and metastatic potential of ESFT cells. 5 In this study, we found that overexpression of EWS, but not DC-NLS (EWS lacking the C-NLS), induced nuclear retention of reporter mRNA in a tethering assay (Figure 1) . Simultaneously, reporter protein expression was increased by DC-NLS, implying that the C-NLS domain of EWS is responsible for inducing the nuclear retention of reporter mRNA, thereby repressing reporter protein expression. The C-NLS (a PY-NLS) is highly conserved between EWS and FUS. Mutations in the PY-NLS of FUS cause amyotrophic lateral sclerosis due to defects in nuclear import of FUS, possibly leading to aberrant mRNA metabolism. 28, 29 In light of the findings reported here, it is worth testing whether mutant FUS affects the nuclear export of mRNA targets.
We hypothesized that other EWS mRNA targets whose protein expression was decreased by EWS could also contribute to progression of ESFT. Here, we found that this is the case for CFL1, a key regulator of actin dynamics. We found that EWS negatively regulated endogenous CFL1 protein and reporter expression through specific binding to the 3 0 -UTR of CFL1 mRNA, without affecting mRNA levels (Figures 2 and 3 ). In agreement with the results of the tethering assay, EWS overexpression repressed CFL1 protein expression and induced the nuclear retention of CFL1 mRNA (Figures 2-4) . Nuclear export of mRNAs requires formation of export-competent messenger ribonucleoprotein complexes, which is tightly coupled with transcription and nuclear processing of mRNAs. Given that only properly spliced mRNAs are exported from the nucleus under normal conditions 30 and that EWS plays a role in mRNA splicing through interaction with splicing factors, 6, 8 it is possible that the splicing defect induced by EWS overexpression may affect the nuclear export of EWS-bound mRNAs. However, we failed to detect any incorrect splicing of either CFL1 mRNA or the tethered reporter mRNA in EWSoverexpressing cells 5 ( Figure 3 and Supplementary Figure S2) . Similarly, we did not detect any difference between the levels of CFL1 mRNA and the tethered reporter mRNA upon either EWS overexpression or knockdown 5 ( Figure 3 ), even though improperly processed mRNAs can be recognized by the nuclear surveillance machinery and targeted for degradation. 30 It is therefore unlikely that EWS repressed the nuclear export of mRNAs by affecting their splicing, at least in our experimental system. EWS localizes to nuclear paraspeckles, which are ribonucleoprotein bodies implicated in the nuclear retention of A-to-I hyperedited mRNAs, 31, 32 and, in our experiments, overexpressed EWS showed speckled patterns in some cells (Figures 1 and 4) . Therefore, EWS-bound mRNAs might be retained at paraspeckles, although to our knowledge there is no evidence that CFL1 mRNA undergoes mRNA editing. Taken together, our results are consistent with a model in which EWS binds to the CFL1 3 0 -UTR to negatively regulate the formation of the exportcompetent CFL1 messenger ribonucleoprotein, resulting in a large decrease in CFL1 protein expression in the cytoplasm. EWS localizes to cytoplasmic stress granules under oxidative stress conditions and is also found in ribosomal fractions, 33, 34 suggesting that it is associated with both translationally repressed and active mRNAs. These observations should be the subject of future investigations.
In good agreement with our data showing that EWS knockdown increased the protein expression of CFL1 (Figure 3 ), lower levels of EWS expression were associated with higher levels of CFL1 expression in ESFT cell lines 5 (Supplementary Figure S3) , suggesting a role for EWS and CFL1 in the pathogenesis of ESFT. CFL1 increases the rate of actin assembly, which supports processes related to actin-based motility; thus, CFL1 is believed to be an important determinant of cell motility. CFL1 contributes to metastasis of many kinds of tumors; 20, 35 consistent with these observations, we showed that silencing CFL1 greatly reduced the migration and invasion of ESFT cells ( Figure 5) . However, the role of CFL1 in cell proliferation has been controversial. After induction of apoptosis in cells, CFL1 translocates from cytosol into mitochondria and seems to contribute to apoptosis, but it is not always required for apoptosis. 36, 37 Cell proliferation is slowed upon CFL1 overexpression in lung cancer cells. 38 On the other hand, levels of phosphorylated (i.e., inactive) CFL1 decline during telophase and cytokinesis. Increased CFL1 phosphorylation induces G2/M arrest and the formation of multinucleate cells, [39] [40] [41] [42] and CFL1-knockdown cells also fail to undergo cytokinesis. 43 These results suggest that activation of cofilin is essential for successful cell division. Our results revealed that silencing CFL1 significantly impaired cell proliferation in ESFT cells ( Figure 6 ). Therefore, we consider that CFL1 is a candidate target for treatment of ESFT.
The results reported here warrant further study on the molecular mechanisms by which CFL1 is involved in the proliferation and metastatic potential of ESFT cells. In future studies, we will also investigate the role of other mRNAs bound and post-transcriptionally regulated by EWS. In ESFT, low expression of native EWS caused by haploinsufficiency results in dysregulation of the entire target mRNA network. Elucidation of this network may provide new insights into the molecular mechanisms of ESFT and point the way toward novel treatment strategies.
MATERIALS AND METHODS Plasmids
The construction of pMS2-3 Â FLAG, pMS2-EWS-3 Â FLAG, pCIneo-Luc, pCIneo-Luc-12 Â MS2, pFLAG-EWS and pFLAG-EWS/FLI-1 was described by Huang et al. 5 To generate the MS2-DC-NLS expression vector, pMS2-DC-NLS-3 Â FLAG, DC-NLS cDNA amplified by PCR from pFLAG-EWS was inserted into the EcoRV-XbaI site of pMS2-3 Â FLAG. The Myc-EWS expression vector pMyc-EWS was constructed by inserting the coding region of EWS isolated from pFLAG-EWS into the NotI-XhoI site of pcDNA3Myc1 (a kind gift from Dr Yasufumi Minami). 44 The CFL1 3 0 -UTR was amplified from HeLa S3 cDNA and inserted into the MluI-SalI site of pCIneo-Luc to yield pCIneo-Luc-CFL1. The CFL1 3 0 -UTR was also inserted into the EcoRI-XbaI site of pGEM3Zf( þ ) to yield pGEM3Zf-CFL1. The coding regions of CFL1 and GAPDH were amplified from HeLa S3 cDNA and inserted into pcDNA3FLAG1 and pGEM-T Easy to yield pFLAG-CFL1 and pGEM-GAPDH, respectively.
Antibodies
Primary antibodies for detection of the following proteins were purchased from commercial suppliers: EWS (G-5, Santa Cruz Biotechnology, Dallas, TX, USA), FLAG (mouse monoclonal clone M2 and rabbit polyclonal antibodies, Sigma, St Louis, MO, USA), b-actin (AC-15, Sigma), CFL1 (Cell Signaling, Danvers, MA, USA), a-tubulin (ICN Biomedicals, Irvine, CA, USA), c-myc (MBL, Nagoya, Japan), digoxigenin (DIG)-AP (Roche, Basel, Switzerland, for northern blotting) and DIG (Abcam, Cambridge, UK, for in situ hybridization). Horseradish peroxide-conjugated anti-mouse IgG and anti-rabbit IgG antibodies (Promega, Madison, WI, USA) and Alexa Fluor 488-conjugated anti-mouse IgG and Alexa Fluor 594-conjugated anti-rabbit IgG antibodies (Invitrogen, Carlsbad, CA, USA) were used as secondary antibodies.
DIG-labeled probes
A 600-bp DNA fragment corresponding to nucleotides 925-1524 of the firefly luciferase-coding region was amplified by PCR with the primer pair 5 0 -TTTTGAATTCTTACACGAAATTGCTTCTGGTGGC-3 0 and 5 0 -TTTTAAGCTTTA ATACGACTCACTATAGGGTTGTTACTTGACTGGCGACGTA-3 0 (the T7 promoter sequence is underlined) using pCIneo-Luc as the template. DIG-labeled RNA probes spanning the coding regions of FLuc, CFL1 and GAPDH were prepared using the resulting DNA fragment, pFLAG-CFL1 and pGEM-GAPDH, respectively, using RNA Labeling Mixture (Roche) according to the manufacturer's instructions.
UV crosslinking
The experiments were performed as described previously. 5 The 32 P-labeled RNA probe spanning the 3 0 -UTR of CFL1 was synthesized with MEGAscript (Ambion, Austin, TX, USA) using pGEM3Zf-CFL1 as the template. FLuc and FLuc-3UTR mRNAs were synthesized with mMESSAGE mMACHINE (Ambion) using pCIneo-Luc and pCIneo-Luc-CFL1 as templates and used as competitor RNAs.
RNA interference
The EWS-knockdown experiments were performed as described previously. 
In situ hybridization and immunofluorescence
In situ hybridization was carried out according to a protocol described by Sone et al. 45 After hybridization and washing steps, the hybridized probes were detected with standard immunohistochemical procedures using mouse anti-DIG antibody for double staining with rabbit anti-FLAG or antic-myc antibodies. 46 Images were acquired using a confocal microscope (FV1000D; Olympus at BOCC, RIKEN) except those shown in Supplementary Figure S1 , which were acquired using a fluorescence microscope (IX81, Olympus, Tokyo, Japan).
Cell culture, MS2 tethering assay, western and northern blotting, real-time PCR, and cell growth, invasion and migration assays These experiments were performed as described by Huang et al. 
